Search Results - "Uoti, Arttu"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

    Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform by Ylösmäki, Erkko, Ylösmäki, Leena, Fusciello, Manlio, Martins, Beatriz, Ahokas, Petra, Cojoc, Hanne, Uoti, Arttu, Feola, Sara, Kreutzman, Anna, Ranki, Tuuli, Karbach, Julia, Viitala, Tapani, Priha, Petri, Jäger, Elke, Pesonen, Sari, Cerullo, Vincenzo

    Published in Molecular therapy. Oncolytics (26-03-2021)
    “…Oncolytic viruses (OVs) have been shown to induce anti-cancer immunity and enhance cancer immunotherapies, such as immune checkpoint inhibitor therapies. OV…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

    A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella by Fusciello, Manlio, Ylösmäki, Erkko, Feola, Sara, Uoti, Arttu, Martins, Beatriz, Aalto, Karri, Hamdan, Firas, Chiaro, Jacopo, Russo, Salvatore, Viitala, Tapani, Cerullo, Vincenzo

    Published in Molecular therapy. Oncolytics (16-06-2022)
    “…Common vaccines for infectious diseases have been repurposed as cancer immunotherapies. The intratumoral administration of these repurposed vaccines can induce…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: